The expression levels of both ESRP1 and ESRP2 were low in normal epithelium but upregulated in precancerous lesions and carcinoma in situ. Expression was maintained in advanced cancer cells but down-regulated on invasive fronts. This evidence concerns the gene ESRP2 and in situ carcinoma.